ホールエクソームシーケンスの世界市場レポート 2025年

ホールエクソームシーケンス市場規模は、今後数年で飛躍的な成長が見込まれます。2029年の年間平均成長率（CAGR）は21.3%で72億9,000万米ドルに成長します。予測期間の成長は、腫瘍学におけるアプリケーションの拡大、臨床診断における統合、遺伝子検査需要の増加、人口ゲノミクスへの取り組み、遺伝子治療の出現に起因しています。予測期間の主な動向には、臨床的有用性の向上と採用、シーケンスコストの低下、データセキュリティとプライバシーの重視、電子カルテとの統合、シングルセルシーケンスの進歩などがあります。

HIV（ヒト免疫不全ウイルス）の流行の高まりが、今後のホールエクソームシーケンス市場の成長を牽引すると予想されます。HIVは身体の免疫システムを攻撃するウイルスです。ホールエクソームシーケンスは、HIVの個別化治療やワクチン開発に役立つウイルスに関するゲノムデータを提供します。例えば、2024年8月、米国の政府機関であるマイノリティHIV/AIDS基金（MHAF）は、2023年に世界で約3,990万人がHIVに感染していると報告し、その内訳は成人3,860万人、子供140万人で、以前に比べて増加していることを示しました。その結果、HIVの有病率の上昇がホールエクソームシーケンス市場の成長に拍車をかけています。

また、個別化医療に対する需要の高まりも、ホールエクソームシーケンス市場の成長を後押ししています。個別化医療は、個人特有の遺伝子構成に合わせた治療を行い、より効果的で正確なヘルスケア介入を提供します。ホールエクソームシーケンスは個別化医療に不可欠であり、個人の遺伝子プロファイルに基づいて治療をカスタマイズし、正確で的を絞った治療を可能にします。2022年、食品医薬品局（FDA）の医薬品評価研究センター（CDER）は37の新規分子実体（NME）を承認し、そのうち約34％（12）は個別化医療連合（PMC）によって個別化医薬品に分類されました。したがって、個別化医療に対する需要の高まりが、ホールエクソームシーケンス市場の成長に大きく寄与しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界ホールエクソームシーケンス PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のホールエクソームシーケンス市場：成長率分析
• 世界のホールエクソームシーケンス市場の実績：規模と成長, 2019-2024
• 世界のホールエクソームシーケンス市場の予測：規模と成長, 2024-2029, 2034F
• 世界ホールエクソームシーケンス総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のホールエクソームシーケンス市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• システム
• キット
• サービス
• 世界のホールエクソームシーケンス市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 合成によるシーケンシング
• イオン半導体シーケンシング
• その他のテクノロジー
• 世界のホールエクソームシーケンス市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 診断
• 医薬品の発見と開発
• パーソナライズ医療
• 農業と動物調査
• 世界のホールエクソームシーケンス市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院と診療所
• 製薬・バイオテクノロジー企業
• 学術研究機関
• 臨床検査室
• その他のエンドユーザー
• 世界のホールエクソームシーケンス市場、システムのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• シーケンシングシステム
• データ分析システム
• 世界のホールエクソームシーケンス市場、キットのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 図書館準備キット
• エクソーム濃縮キット
• シーケンシングキット
• 世界のホールエクソームシーケンス市場、サービスの種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• データ分析サービス
• コンサルティングサービス
• カスタムシーケンスサービス

第7章 地域別・国別分析

• 世界のホールエクソームシーケンス市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のホールエクソームシーケンス市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ホールエクソームシーケンス市場：競合情勢
• ホールエクソームシーケンス市場：企業プロファイル
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Eurofins Genomics Overview, Products and Services, Strategy and Financial Analysis
  • Azenta US Inc. Overview, Products and Services, Strategy and Financial Analysis
  • CD Genomics Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Psomagen Inc.
• Agilent Technologies
• BGI Genomics
• F. Hoffmann-La Roche Ltd.
• QIAGEN Inc.
• Macrogen Inc.
• Ambry Genetics
• Bio-Rad Laboratories Inc.
• Bioneer Corporation
• Foundation Medicine Inc.
• KONICA MINOLTA INC.
• Otogenetics Corporation
• Geneyx Genomex Ltd.
• ArcherDX Inc.
• Blueprint Genetics Oy

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ホールエクソームシーケンス市場2029：新たな機会を提供する国
• ホールエクソームシーケンス市場2029：新たな機会を提供するセグメント
• ホールエクソームシーケンス市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Whole exome sequencing is a genomic sequencing method that involves sequencing all the protein-coding regions within a genome. This laboratory technique is utilized to identify mutations that could be linked to a specific disease.

The primary offerings in the field of whole exome sequencing include systems, kits, and services. The term "system" pertains to the examination of how biological components such as molecules, cells, and organs interact and function. Various technologies, such as sequencing by synthesis, ion semiconductor sequencing, and others, are employed for applications in diagnostics, drug discovery and development, personalized medicine, agriculture, and animal research. These applications are utilized by hospitals and clinics, pharmaceutical and biotechnology companies, academic and research institutes, clinical laboratories, and other entities.

The whole exome sequencing market research report is one of a series of new reports from The Business Research Company that provides whole exome sequencing market statistics, including the whole exome sequencing industry global market size, regional shares, competitors with a whole exome sequencing market share, detailed whole exome sequencing market segments, market trends, and opportunities, and any further data you may need to thrive in the whole exome sequencing industry. This whole exome sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The whole exome sequencing market size has grown rapidly in recent years. It will grow from$2.82 billion in 2024 to $3.37 billion in 2025 at a compound annual growth rate (CAGR) of 19.4%. The growth in the historic period can be attributed to genomic research advancements, precision medicine trends, rare disease diagnosis, pharmaceutical and biotech applications, declining sequencing costs

The whole exome sequencing market size is expected to see exponential growth in the next few years. It will grow to $7.29 billion in 2029 at a compound annual growth rate (CAGR) of 21.3%. The growth in the forecast period can be attributed to expanding applications in oncology, integration in clinical diagnostics, rise in genetic testing demand, population genomics initiatives, emergence of gene therapies. Major trends in the forecast period include enhanced clinical utility and adoption, decreasing costs of sequencing, focus on data security and privacy, integration with electronic health records, advances in single-cell sequencing.

The rising prevalence of HIV (human immunodeficiency virus) is anticipated to drive the growth of the whole exome sequencing market in the future. HIV is a virus that attacks the body's immune system. Whole exome sequencing provides genomic data about viruses that can be valuable for personalized treatments and vaccine development for HIV. For example, in August 2024, the Minority HIV/AIDS Fund (MHAF), a US-based government agency, reported that in 2023, around 39.9 million people worldwide were living with HIV, which includes 38.6 million adults and 1.4 million children, showing an increase compared to previous years. Consequently, the rising prevalence of HIV is fueling the growth of the whole exome sequencing market.

The rising demand for personalized medicine is also poised to drive the growth of the whole exome sequencing market. Personalized medicine tailors medical treatment to an individual's unique genetic makeup, offering more effective and precise healthcare interventions. Whole exome sequencing is integral to personalized medicine, enabling the customization of treatments based on an individual's genetic profile for precise and targeted therapies. In 2022, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs), with approximately 34% (12 of them) classified as personalized medicines by the Personalized Medicine Coalition (PMC). Hence, the increasing demand for personalized medicine is a significant factor contributing to the growth of the whole exome sequencing market.

A prominent trend gaining traction in the whole exome sequencing market is the adoption of innovative diagnostic techniques. Companies within this market are actively engaged in developing new product innovations to maintain their market positions. For example, in February 2023, Illumina Inc., a biotechnology company based in the United States, introduced the NovaSeqX Plus, a state-of-the-art sequencing technology. This groundbreaking technology combines high throughput and accuracy, featuring streamlined informatics, sustainability advancements, and cost-effective sequencing. The NovaSeq X Plus systems are equipped with innovations capable of generating tens of thousands of whole genomes annually, enhancing productivity, and minimizing turnaround time.

Leading companies in the whole exome sequencing market are developing advanced next-generation sequencing (NGS) ultra-fast technology to improve the speed and accuracy of genetic analyses, facilitating quicker diagnostics and personalized treatment plans in healthcare. This NGS ultra-fast technology enhances whole exome sequencing by rapidly analyzing exonic regions, enabling the swift detection of genetic mutations that are vital for diagnosis and research. For example, in January 2023, Qiagen, a medical devices and healthcare company based in Germany, introduced the CLC Genomics Workbench Premium with Lightspeed technology. This innovation allows for efficient analysis of whole genome sequencing (WGS) and whole exome sequencing (WES) data, processing an entire genome in just 25 minutes for approximately $1 using cloud computing, while also supporting local hardware. By decreasing both time and costs, Lightspeed improves the accessibility of large-scale genetic testing in the WES market.

In January 2022, Exact Sciences, a molecular diagnostics company in the United States, acquired Prevention Genetics for a deal valued at $190 million. This strategic acquisition strengthened Exact Sciences' advanced cancer testing portfolio. Prevention Genetics, a clinical DNA testing laboratory based in the U.S., is known for providing high-quality genetic testing and services to patients and researchers.

Major companies operating in the whole exome sequencing market include Thermo Fisher Scientific Inc., Illumina Inc., Eurofins Genomics, Azenta US Inc., CD Genomics, Psomagen Inc., Agilent Technologies, BGI Genomics, F. Hoffmann-La Roche Ltd., QIAGEN Inc., Macrogen Inc., Ambry Genetics, Bio-Rad Laboratories Inc., Bioneer Corporation, Foundation Medicine Inc., KONICA MINOLTA INC., Otogenetics Corporation, Geneyx Genomex Ltd., ArcherDX Inc., Blueprint Genetics Oy, Bionano Genomics Inc., Centogene AG, Fulgent Genetics Inc., Natera Inc., GeneDx Inc., GENEWIZ Inc., Novogene Corporation, PerkinElmer Inc., Personalis Inc.

North America was the largest region in the whole exome sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global whole exome sequencing market report during the forecast period. The regions covered in the whole exome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the whole exome sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The whole exome sequencing market consists of revenues earned by entities by providing services such as exome capture, library construction, deep sequencing, raw data quality control, and bioinformatics analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The whole exome sequencing market also includes sales of instruments, comparison tools, and sequencing reagents which are used in providing whole exome sequencing services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Whole Exome Sequencing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on whole exome sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for whole exome sequencing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The whole exome sequencing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Systems; Kits; Services
• 2) By Technology: Sequencing By Synthesis; Ion Semiconductor Sequencing; Other Technologies
• 3) By Application: Diagnostics; Drug Discovery And Development; Personalized Medicine; Agriculture And Animal Research
• 4) By End-User: Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Academic and Research Institutes; Clinical Laboratories; Other End-Users
• Subsegments:
• 1) By Systems: Sequencing Systems; Data Analysis Systems
• 2) By Kits: Library Preparation Kits; Exome Enrichment Kits; Sequencing Kits
• 3) By Services: Data Analysis Services; Consulting Services; Custom Sequencing Services
• Companies Mentioned: Thermo Fisher Scientific Inc.; Illumina Inc.; Eurofins Genomics; Azenta US Inc.; CD Genomics
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Whole Exome Sequencing Market Characteristics

3. Whole Exome Sequencing Market Trends And Strategies

4. Whole Exome Sequencing Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Whole Exome Sequencing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Whole Exome Sequencing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Whole Exome Sequencing Market Growth Rate Analysis
• 5.4. Global Whole Exome Sequencing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Whole Exome Sequencing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Whole Exome Sequencing Total Addressable Market (TAM)

6. Whole Exome Sequencing Market Segmentation

• 6.1. Global Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Systems
• Kits
• Services
• 6.2. Global Whole Exome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sequencing By Synthesis
• Ion Semiconductor Sequencing
• Other Technologies
• 6.3. Global Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostics
• Drug Discovery and Development
• Personalized Medicine
• Agriculture and Animal Research
• 6.4. Global Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals and Clinics
• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutes
• Clinical Laboratories
• Other End-Users
• 6.5. Global Whole Exome Sequencing Market, Sub-Segmentation Of Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sequencing Systems
• Data Analysis Systems
• 6.6. Global Whole Exome Sequencing Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Library Preparation Kits
• Exome Enrichment Kits
• Sequencing Kits
• 6.7. Global Whole Exome Sequencing Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Data Analysis Services
• Consulting Services
• Custom Sequencing Services

7. Whole Exome Sequencing Market Regional And Country Analysis

• 7.1. Global Whole Exome Sequencing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Whole Exome Sequencing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Whole Exome Sequencing Market

• 8.1. Asia-Pacific Whole Exome Sequencing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Whole Exome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Whole Exome Sequencing Market

• 9.1. China Whole Exome Sequencing Market Overview
• 9.2. China Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Whole Exome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Whole Exome Sequencing Market

• 10.1. India Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Whole Exome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Whole Exome Sequencing Market

• 11.1. Japan Whole Exome Sequencing Market Overview
• 11.2. Japan Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Whole Exome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Whole Exome Sequencing Market

• 12.1. Australia Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Whole Exome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Whole Exome Sequencing Market

• 13.1. Indonesia Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Whole Exome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Whole Exome Sequencing Market

• 14.1. South Korea Whole Exome Sequencing Market Overview
• 14.2. South Korea Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Whole Exome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Whole Exome Sequencing Market

• 15.1. Western Europe Whole Exome Sequencing Market Overview
• 15.2. Western Europe Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Whole Exome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Whole Exome Sequencing Market

• 16.1. UK Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Whole Exome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Whole Exome Sequencing Market

• 17.1. Germany Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Whole Exome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Whole Exome Sequencing Market

• 18.1. France Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Whole Exome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Whole Exome Sequencing Market

• 19.1. Italy Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Whole Exome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Whole Exome Sequencing Market

• 20.1. Spain Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Whole Exome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Whole Exome Sequencing Market

• 21.1. Eastern Europe Whole Exome Sequencing Market Overview
• 21.2. Eastern Europe Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Whole Exome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Whole Exome Sequencing Market

• 22.1. Russia Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Whole Exome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Whole Exome Sequencing Market

• 23.1. North America Whole Exome Sequencing Market Overview
• 23.2. North America Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Whole Exome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Whole Exome Sequencing Market

• 24.1. USA Whole Exome Sequencing Market Overview
• 24.2. USA Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Whole Exome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Whole Exome Sequencing Market

• 25.1. Canada Whole Exome Sequencing Market Overview
• 25.2. Canada Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Whole Exome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Whole Exome Sequencing Market

• 26.1. South America Whole Exome Sequencing Market Overview
• 26.2. South America Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Whole Exome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Whole Exome Sequencing Market

• 27.1. Brazil Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Whole Exome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Whole Exome Sequencing Market

• 28.1. Middle East Whole Exome Sequencing Market Overview
• 28.2. Middle East Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Whole Exome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Whole Exome Sequencing Market

• 29.1. Africa Whole Exome Sequencing Market Overview
• 29.2. Africa Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Whole Exome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Whole Exome Sequencing Market Competitive Landscape And Company Profiles

• 30.1. Whole Exome Sequencing Market Competitive Landscape
• 30.2. Whole Exome Sequencing Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Eurofins Genomics Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Azenta US Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. CD Genomics Overview, Products and Services, Strategy and Financial Analysis

31. Whole Exome Sequencing Market Other Major And Innovative Companies

• 31.1. Psomagen Inc.
• 31.2. Agilent Technologies
• 31.3. BGI Genomics
• 31.4. F. Hoffmann-La Roche Ltd.
• 31.5. QIAGEN Inc.
• 31.6. Macrogen Inc.
• 31.7. Ambry Genetics
• 31.8. Bio-Rad Laboratories Inc.
• 31.9. Bioneer Corporation
• 31.10. Foundation Medicine Inc.
• 31.11. KONICA MINOLTA INC.
• 31.12. Otogenetics Corporation
• 31.13. Geneyx Genomex Ltd.
• 31.14. ArcherDX Inc.
• 31.15. Blueprint Genetics Oy

32. Global Whole Exome Sequencing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Whole Exome Sequencing Market

34. Recent Developments In The Whole Exome Sequencing Market

35. Whole Exome Sequencing Market High Potential Countries, Segments and Strategies

• 35.1 Whole Exome Sequencing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Whole Exome Sequencing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Whole Exome Sequencing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer